On the recordNovember 13, 2012
I agree with him, and that is why I think he probably should consider being the commission chairman.
Source
congress.govEditor's note · Context
Sarbanes supports the idea of a proactive FDA leadership for safety.
Share
More from John Sarbanes
Apr 18, 2023
I do also want to commend my colleague, Representative Blunt Rochester, for the work that she has been doing.
May 9, 2023
Without the strong and continued investment the EPA has requested for the Chesapeake Bay Program in fiscal year 2024, the risk is we could jeopardize decades of work in collaboration towards the Bay's restoration.
Apr 25, 2023
Maryland's total-cost-of-care model also allows our State to invest in other health system goals, like lowering the maternal mortality rate and the opioid overdose mortality rate.
Mar 1, 2023
Due to testing positive for COVID-19 and following recommended isolation protocols, I was unable to vote. Had I been present, I would have voted ``aye'' on rollcall No. 125, ``aye'' on rollcall No. 126, ``aye'' on rollcall No. 127, ``aye''…
Other voices in this conversation
